CDMO Catalent to Help with Cell Therapy Studies


CDMO Catalent states that their new manufacturing facility will be used to assist both autologous and allogeneic cell therapy studies. The facility has a total area of 60,000 square feet. Catalent Acquires Masthercell to Expand Cell Therapy Options In the year 2020, Catalent completed the acquisition of Masthercell from Orgenesis. This provided them with more […]